THE MINISTRY OF HEALTH

Circular No.  36/2015/TT-BYT dated October 29, 2015 of the Ministry of health on amending a number of Articles of the Circular No.  40/2014/TT-BYT dated November 17,  2014 on issuing and guiding the implementation of the List of modern medicines covered by health insurance
Pursuant to the Law on Health insurance;
Pursuant to Decree No. 63/2012/ND-CP dated August 31, 2012 by the Government defining the functions, tasks, entitlements and organizational structure of the Ministry of Health;
Pursuant to Decree No. 105/2014/ND-CP dated November 15, 2014 by the Government providing guidance on the implementation of a number of articles of the Law on Health insurance;
The Minister of Health hereby promulgates the Circular amending a number of articles of Circular No. 40/2014/TT-BYT dated November 17, 2014 on issuing and guiding the implementation of the List of modern medicines covered by health insurance.
Article 1. To amend a number of articles of Circular No. 40/2014/TT-BYT dated November 17, 2014:
1. To amend the List of modern medicines enclosed with Circular No. 40/2014/TT-BYT dated November 17, 2014 as follows:
a) “Anti-human thymocyte immunoglobulin” (No. 340, column 2) is changed to “Anti thymocyte globulin”;
b) “Hydroxycarbamid” (No. 370, column 2) is changed to “Hydroxycarbamid / Hydroxyurea”;
c) “Methoxy polyethylene glycol epoietin beta” (No. 474, column 2) is changed to “Methoxy polyethylene glycol epoetin beta”;
d) “S-bioballthrin + piperonylbutoxid” (No. 605, column 2) is changed to “S-bioallethrin + piperonyl butoxid”;
dd) “Activated attapulgite mormoivon + magnesium carbonate - aluminum hydroxide mixture” (No. 663, column 2) is changed to ““Activated attapulgite mormoiron + magnesium carbonate - aluminum hydroxide mixture”;
e) “Acid thioctic; Meglumin thioctat” (No. 940, column 2) is changed to “Acid thioctic/ Meglumin thioctat”;
g) The note “Health insurance covers the treatment of stroke, posttraumatic treatment and traumatic brain injury surgery and cranial nerve postoperative treatment” (Column 9 of Peptid (Cerebrolysin concentrate), No. 561, column 2; Choline alfoscerat, No. 562, column 2 and Citicolin, No. 563, column 2) is changed to “Health insurance covers the treatment of acute stroke, posttraumatic treatment and traumatic brain injury surgery and cranial nerve postoperative treatment”;